Emami Limited has informed the Exchange about Acquisition
EMAMILTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emami Limited's board, on 31st March 2026, approved acquiring the remaining ~73.5% stake in its associate company Axiom Ayurveda Private Limited (AAPL) for a cash consideration of up to Rs. 200 Crores. This will take Emami's holding from ~26.5% to 100%, making AAPL a wholly-owned subsidiary. AAPL operates in the FMCG healthy beverages space (aloe vera pulp with fruit blends) and also has a small presence in personal care (~15-20% of its own branded business). Its turnover was Rs. 110 Cr in FY25, Rs. 107 Cr in FY24, and Rs. 129 Cr in FY23. The transaction is expected to be completed by 30th June 2026, is not a related-party deal, and requires no government approvals.
This move gives Emami full strategic and operational control over a growing healthy beverages business, strengthening its FMCG portfolio beyond its core personal care segments. The Rs. 200 Cr cash outflow is a moderate size relative to typical Emami acquisitions and should be earnings-accretive once AAPL is fully consolidated. The stock may see a mildly positive reaction as it signals focused inorganic expansion in a high-growth category.